PRMT1 Ablation in Endothelial Cells Causes Endothelial Dysfunction and Aggravates COPD Attributable to Dysregulated NF‐κB Signaling
Advanced Science · 2025
DOI: 10.1002/advs.202411514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Thi Thuy Vy Tran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, 2066, Seobu-Ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of K…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Pulmonary Disease, Chronic Obstructive, NF-kappa B, Endothelial Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Korea Government (MSIT), Korea Health Industry Development Institute.
Themen: COPD
Abstract (Originalsprache)
Endothelial dysfunction and senescence are pivotal in pulmonary diseases, including chronic obstructive pulmonary disease (COPD). Protein arginine methyltransferase 1 (PRMT1) is the major enzyme responsible for asymmetric arginine dimethylation and plays a role in diverse biological processes, including cardiovascular function. Yet, its role in endothelial cells (ECs) remains poorly understood. Here, the role of PRMT1 is investigated in ECs, particularly in the context of COPD pathogenesis. Endothelial‐specific PRMT1 knockout mice exhibit pulmonary hemorrhage, inflammation, barrier disruption, and apoptosis, accompanied by hyperactivation of nuclear factor kappa B (NF‐κB). Bulk RNA sequencing of whole lungs and single‐cell RNA sequencing of pulmonary ECs reveal that endothelial PRMT1 ablation results in a major alteration in inflammation‐related gene expression. In a COPD model, PRMT1 deficiency aggravates the COPD phenotypes, including enlarged alveolar spaces, increased cell death, and senescence. PRMT1 inhibition in ECs exacerbates tumor necrosis factor alpha‐triggered EC senescence and dysfunction attributable to NF‐κB hyperactivation. PRMT1 as a critical regulator of pulmonary EC function, preventing NF‐κB‐driven endothelial dysfunction and senescence is highlighted here.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, 2066, Seobu-Ro, Jangan-gu, Suwon, Gyeonggi-do, 16419, Republic of Korea.
- Research Institute of Aging Related Disease, AniMusCure Inc., Suwon, 16419, Republic of Korea.
- Department of Chemistry, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
- Drug Information Research Institute, Muscle Physiome Research Center, College of Pharmacy, Sookmyung Women's University, Cheongpa-ro 47-gil 100, Yongsan-gu, Seoul, 04310, Republic of Korea.
ORCID-Profile: Thi Thuy Vy Tran, Yideul Jeong, Ji Eun Yeom, Jinwoo Lee, Wonhwa Lee, Gyu-Un Bae, Jong-Sun Kang
Förderung
- National Research Foundation
- Korea Government (MSIT)
- Korea Health Industry Development Institute
- Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Tran, T. T. V., Jeong, Y., Kim, S., Yeom, J. E., Lee, J., Lee, W., Bae, G. U., & Kang, J. S. (2025). PRMT1 Ablation in Endothelial Cells Causes Endothelial Dysfunction and Aggravates COPD Attributable to Dysregulated NF‐κB Signaling. Advanced Science. https://doi.org/10.1002/advs.202411514
Vancouver
Tran TTV, Jeong Y, Kim S, Yeom JE, Lee J, Lee W, et al. PRMT1 Ablation in Endothelial Cells Causes Endothelial Dysfunction and Aggravates COPD Attributable to Dysregulated NF‐κB Signaling. Advanced Science. 2025. doi:10.1002/advs.202411514
BibTeX
@article{Tran2025,
author = {Tran, Thi Thuy Vy and Jeong, Yideul and Kim, Suwoo and Yeom, Ji Eun and Lee, Jinwoo and Lee, Wonhwa and Bae, Gyu-Un and Kang, Jong-Sun},
title = {PRMT1 Ablation in Endothelial Cells Causes Endothelial Dysfunction and Aggravates COPD Attributable to Dysregulated NF‐κB Signaling},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411514}
}
EUVIMED